Viral Infection

There is a research paper here  which establishes the link showing that a course of anti virals can improve Menieres symptoms in some cases.

Viral infection is only one of a number of different potential causes of Meniere’s Disease. Without testing for a viral infection it might be possible to get your GP to agree to a course of anti virals to see if they will help relieve your Menieres symptoms.

Famvir is probably the most recommended for such a trial as it crosses the blood brain barrier most effectively.

Valtrax is also an option as it contains valaciclovir, which is used to treat infections caused by herpes viruses. In adults, Valtrex is used to treat genital herpes, cold sores, and shingles (herpes zoster) and in children it can be used to treat chickenpox. It works by slowing down the growth of the herpes virus which gives the body a chance to fight the infection. It decreases the severity and duration of these outbreaks

The dosage is also important for a course of anti virals and potentially should start with a higher dosage before settling down to a maintenance dosage.

For example : Valtrex start at 3000 mg a day for the first three weeks; 2000 mg for the next three weeks; and down to 1000 mg after that.

The virus theory has been backed up by research at the MRFi in Sydney Australia who are running a trial to identify a virus in the body of Meniere’s sufferers and then clear the virus by increasing the circulating antibodies within the body.

There is a great presentation here explaining how Meniere’s symptoms occur in your ear.

It’s given by World Leading Meniere’s expert Professor Bill Gibson at the Meniere’s Research Foundation institute (MRFi) at their 5th Annual Symposium in Sydney Australia on 3rd November 2018. 

He explains his theory of how a virus can persist within the inner ear even though it may not show up on standard blood tests.

He starts at 1:11:08 describing how a Meniere’s attack occurs.
At 1:25:00 he explains how he is trying in his proposed human study to identify a virus in the body and then boost the circulating antibodies to destroy it before it reaches the Endolymphatic Sac or Cochlea.

The resulting treatment programme could be a course of the appropriate anti virals to address any virus found.